News Conference News ESOC 2026 HOPE Supports Tailored Approach to BP After Stroke Thrombectomy Considering some unique trial features, the results should be seen “more as hypothesis-generating than practice-changing.” Todd Neale May 06, 2026
Presentation ACC 2025 STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes Presenter: Marc P. Bonaca March 29, 2025
Presentation ACC 2025 Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study Presenter: Isabelle Mahé March 29, 2025
Presentation Miami Valves 2025 Something in the Way: An RV in Crisis Presenter: Enrique Soltero Mariscal January 30, 2025
Presentation Miami Valves 2025 A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement Presenter: Lourdes Villarrubia Varela January 30, 2025
Presentation Cardiovascular Interventions 2024 Building Your PERT Team: Designing the Right Team with the Right Technology Presenter: Curtiss T. Stinis November 11, 2024
News Conference News EuroPCR 2026 What’s Going to Be Hot at EuroPCR 2026? By Michael O'Riordan May 11, 2026
News Conference News Fellows 2026 CRF Fellows Course 2026: What to Expect in Miami Beach By Yael L. Maxwell May 11, 2026
News Conference News ESOC 2026 Mixed Results for Targeted Focal Cooling During Stroke Thrombectomy By Todd Neale May 08, 2026
News Conference News ESOC 2026 HOPE Supports Tailored Approach to BP After Stroke Thrombectomy By Todd Neale May 06, 2026